Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial-论文-万方医学网

首页> > Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

导出原文传递

翻译打印收藏纠错

第一作者： Susana Ravassa

作者： Susana Ravassa ^[1] ; Bego?a López ^[2] ; Jo?o Pedro Ferreira ^[3] ; Nicolas Girerd ^[4] ; Erwan Bozec ^[5] ; Pierpaolo Pellicori ^[6] ; Beatrice Mariottoni ^[7] ; Franco Cosmi ^[8] ; Mark Hazebroek ; Job A.J. Verdonschot ; Joe Cuthbert ; Johannes Petutschnigg ; María U. Moreno ; Stephane Heymans ; Jan A. Staessen ; Burkert Pieske ; Frank Edelmann ; Andrew L. Clark ; John G.F. Cleland ; Faiez Zannad ; Javier Díez ; Arantxa González

作者单位： Department of Cardiology,Cortona Hospital ^[1] Department of Internal Medicine and Cardiology Campus Virchow Klinikum,Charité University Medicine ^[2] Department of Cardiology,Maastricht University Medical Center ^[3] Robertson Centre for Biostatistics, Institute of Health and Wellbeing,University of Glasgow ^[4] Program of Cardiovascular Diseases, CIMA,Universidad de Navarra and IdiSNA ^[5] Department of Cardiology,University of Hull, Castle Hill Hospital ^[6] Université de Lorraine, Inserm, Centre d'Investigation Clinique Plurithématique 1433, U1116, CHRU ^[7] Non‐Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechelen (APPREMED) ^[8]

关键词 Heart failure Spironolactone Atrial remodelling Collagen cross‐linking

发布时间 2022-04-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

法律状态公告日	法律状态	法律状态信息

检索历史清除

Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

相似文献

同项目论文

相关期刊

检索历史 清除

Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

相似文献

同项目论文

相关期刊

检索历史清除